[Activity of serum and lymphocyte serine proteases of patients with diabetes mellitus and the possibility of using protease blockers in combined therapy].
The role of serine proteases of trypsin type was shown in the pathogenesis of autoimmune processes and nonspecific reactivity in diabetes mellitus. The use of protease blockers and thymic hormonal factors was proposed for patients suffering from diabetes mellitus with changed immunological reactivity.
Efimov
A S
AS
Vaniurikhina
L T
LT
Orlova
A V
AV
D000293:Adolescent; D000328:Adult; D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000097:blood*; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000201:enzymology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008875:Middle Aged; D011480:Protease Inhibitors / Q000627:therapeutic use*; D012697:Serine Endopeptidases / Q000097:blood*; D013154:Spleen / Q000166:cytology; D013950:Thymus Gland / Q000166:cytology
D011480:Protease Inhibitors; D007611:Aprotinin; D012697:Serine Endopeptidases
Aktivnost' serinovykh proteaz syvorotki krovi i limfotsitov bol'nykh sakharnym diabetom i vozmozhnosti primeneniia blokatorov proteaz v kompleksnoĭ terapii.